M1194 - Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)

HCPCS Code: M1194
Long Description: Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)
Short Description: Med rsn no imp/con mmr/msi

Original information is taken from M1194 page

Pricing Indicator Code 1: 00 – Service not separately priced by part B (e.g., services not covered, bundled, used by part a only, etc.)
Multiple Pricing Indicator Code 9 : Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99')

Coverage: C – Carrier judgment

Berenson-Eggers Type of Service (BETOS): Z2 – Undefined codes
Type Of Service 1: 1 – Medical care

Anesthesia Base Unit Quantity: 0
Code Added Date: 20230101
Code Effective Date: 20230101
Action Code: N – No maintenance for this code

HCPCS M1194 Code. Med rsn no imp/con mmr/msi

General information on the “M1194” code

Pricing indicators

Certification and additional reference information

Coverage

Type of service

Misc information